Abstract:<section class="article-section__content">Quantitative physiological parameters can be obtained from nonlinear pharmacokinetic models, such as the extended Tofts (eTofts) model, applied to dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI). However, the computation of such nonlinear models is time consuming. The aim of this study was to develop a convolutional neural network (CNN) for accelerating the computation of fitting eTofts model without sacrificing agreement with conventional nonlinear‐least‐square (NLLS) fitting. This was a retrospective study, which included 13 patients with brain glioma for training (75%) and validation (25%), and 11 patients (three glioma, four brain metastases, and four lymphoma) for testing. CAIPIRINHA‐Dixon‐TWIST DCE‐MRI and double flip angle T1 map acquired at 3 T were used. A CNN with both local pathway and global pathway modules was designed to estimate the eTofts model parameters, the volume transfer constant (Ktrans), blood volume fraction (vp), and volume fraction of extracellular extravascular space (ve), from DCE‐MRI data of tumor and normal‐appearing voxels. The CNN was trained on mixed dataset consisting of synthetic and patient data. The CNN result and computation speed were compared with NLLS fitting. The robustness to noise variations and generalization to brain metastases and lymphoma data were also evaluated. Statistical tests used were Student's t test on mean absolute error, concordance correlation coefficient (CCC), and normalized root mean squared error. Including global pathway modules in the CNN and training the network with mixed data significantly (p < 0.05) improved the CNN performance. Compared with NLLS fitting, CNN yields an average CCC greater than 0.986 for Ktrans, greater than 0.965 for vp, and greater than 0.948 for ve. The CNN accelerated computation speed approximately 2000 times compared to NLLS, showed robustness to noise (signal‐to‐noise ratio >34.42 dB), and had no significant (p > 0.21) difference applied to brain metastases and lymphoma data. In conclusion, the proposed CNN to estimate eTofts parameters showed comparable result as NLLS fitting while significantly reducing the computation time. </section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3>3</section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3>1</section>

Efficient estimation of pharmacokinetic parameters from breast dynamic contrast-enhanced MRI based on a convolutional neural network for predicting molecular subtypes

Deconvolution-Based Pharmacokinetic Analysis to Improve the Prediction of Pathological Information of Breast Cancer

Noninvasive assessment of breast cancer molecular subtypes on multiparametric MRI using convolutional neural network with transfer learning

A Clinically Feasible Method to Estimate Pharmacokinetic Parameters in Breast Cancer

Raman spectroscopy combined with convolutional neural network for the sub-types classification of breast cancer and critical feature visualization

Convolutional neural network for accelerating the computation of the extended Tofts model in dynamic contrast‐enhanced magnetic resonance imaging

Deep learning prediction of pathological complete response, residual cancer burden, and progression-free survival in breast cancer patients

Multimodal Deep Learning to Differentiate Tumor Recurrence from Treatment Effect in Human Glioblastoma

Prediction of breast cancer molecular subtypes on DCE-MRI using convolutional neural network with transfer learning between two centers

Machine Learning Approaches to Radiogenomics of Breast Cancer using Low-Dose Perfusion Computed Tomography: Predicting Prognostic Biomarkers and Molecular Subtypes

Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer

Prediction of breast cancer molecular subtypes using DCE-MRI based on CNNs combined with ensemble learning

Quantitative pharmacokinetic parameter K trans map assists in regional segmentation of nasopharyngeal carcinoma in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)

A deep learning model based on dynamic contrast-enhanced magnetic resonance imaging enables accurate prediction of benign and malignant breast lessons

Prediction of epidermal growth factor receptor (EGFR) mutation status in lung adenocarcinoma patients on computed tomography (CT) images using 3-dimensional (3D) convolutional neural network

An Automated Approach for Predicting Glioma Grade and Survival of LGG Patients Using CNN and Radiomics.

Cross-attention multi-branch CNN using DCE-MRI to classify breast cancer molecular subtypes

Prior Clinico‐Radiological Features Informed Multi‐Modal MR Images Convolution Neural Network: A novel deep learning framework for prediction of lymphovascular invasion in breast cancer

CNN-based automatic segmentations and radiomics feature reliability on contrast-enhanced ultrasound images for renal tumors

Advancing EGFR mutation subtypes prediction in NSCLC by combining 3D pretrained ConvNeXt, radiomics, and clinical features

Potential of the Non-Contrast-Enhanced Chest CT Radiomics to Distinguish Molecular Subtypes of Breast Cancer: A Retrospective Study